000 | 00972 a2200277 4500 | ||
---|---|---|---|
005 | 20250518044806.0 | ||
264 | 0 | _c20200309 | |
008 | 202003s 0 0 eng d | ||
022 | _a1933-2874 | ||
024 | 7 |
_a10.1016/j.jacl.2019.05.009 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGrundy, Scott M | |
245 | 0 | 0 |
_aElevated apolipoprotein B as a risk-enhancing factor in 2018 cholesterol guidelines. _h[electronic resource] |
260 |
_bJournal of clinical lipidology _c |
||
300 |
_a356-359 p. _bdigital |
||
500 | _aPublication Type: Editorial; Comment | ||
650 | 0 | 4 | _aAmerican Heart Association |
650 | 0 | 4 | _aApolipoproteins B |
650 | 0 | 4 | _aCardiology |
650 | 0 | 4 | _aCholesterol |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aProliferating Cell Nuclear Antigen |
700 | 1 | _aStone, Neil J | |
773 | 0 |
_tJournal of clinical lipidology _gvol. 13 _gno. 3 _gp. 356-359 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jacl.2019.05.009 _zAvailable from publisher's website |
999 |
_c29825868 _d29825868 |